VYNE
Vyne Therapeutics Inc
NASDAQ: VYNE · HEALTHCARE · BIOTECHNOLOGY
$0.67
+0.53% today
Updated 2026-05-06
Market cap
$21.39M
P/E ratio
—
P/S ratio
37.52x
EPS (TTM)
$-0.63
Dividend yield
—
52W range
$0 – $2
Volume
0.2M
Vyne Therapeutics Inc (VYNE) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |